- 2026-12-06
-
Disitamab vedotin–based therapy in HER2-expressing platinum-sensitive recurrent ovarian, peritoneal, or fallopian tube cancer: DIVERSITY study
07:53-08:00
Room 502
Mini Oral
Speaker
-
A non-invasive three-gene cfDNA methylation panel for the early detection of epithelial ovarian cancer: development and independent validation
13:35-13:42
Room 502
Mini Oral
Speaker


